Silke Zinke

Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis

A. Zink, Jörn Kekow, Karin Rockwitz et al. · Arthritis Research & Therapy · 2016 · 66 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register

Martin Schäfer, Katinka Albrecht, Joern Kekow et al. · RMD Open · 2023 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sensitivity and Specificity of Autoantibodies Against <scp>CD</scp>74 in Nonradiographic Axial Spondyloarthritis

E. Riechers, N.T. Baerlecken, Xenofon Baraliakos et al. · Arthritis & Rheumatology · 2018 · 37 citations

Life Sciences, Immunology, Autoimmunity +16

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany

Hans‐Peter Tony, Eugen Feist, Peer Aries et al. · Rheumatology Advances in Practice · 2022 · 18 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort

Andreas Reich, Anja Weiß, Lisa Lindner et al. · Arthritis Research & Therapy · 2023 · 16 citations · Full text

Medicine, Psychiatry, Psychoneuroimmunology +14